Barak Zafrir

Summary

Publications

  1. ncbi request reprint Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, 7 Michal St, Haifa, Israel
    Cardiovasc Drugs Ther 28:361-77. 2014
  2. ncbi request reprint Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Cardiopulm Rehabil Prev 33:263-73. 2013
  3. doi request reprint The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox"
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Respir Med 107:139-46. 2013
  4. doi request reprint Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Congest Heart Fail 18:254-61. 2012
  5. ncbi request reprint Joint impact of body mass index and physical capacity on mortality in patients with systolic heart failure
    Barak Zafrir
    Heart Failure Unit, Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and Heart Failure Clinic, Lin Medical Center, Haifa, Israel Electronic address
    Am J Cardiol 113:1217-21. 2014
  6. doi request reprint Absence of the α(2c)-adrenoceptor Del322-325 allele is associated with increased mortality in patients with chronic systolic heart failure
    Offer Amir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Card Fail 18:925-9. 2012
  7. ncbi request reprint Single measurement of serum N-terminal pro-brain natriuretic peptide: the best predictor of long-term mortality in patients with chronic systolic heart failure
    Roni Berin
    The Bruce and Ruth Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Intern Med 25:458-62. 2014
  8. doi request reprint A novel approach to monitoring pulmonary congestion in heart failure: initial animal and clinical experiences using remote dielectric sensing technology
    Offer Amir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Congest Heart Fail 19:149-55. 2013
  9. ncbi request reprint Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives
    Barak Zafrir
    Department of Cardiovascular Medicine, Carmel Medical Center and Heart Failure Center, Lin Medical Center, affiliated with Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Isr Med Assoc J 14:184-9. 2012
  10. doi request reprint Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Intern Med 22:53-6. 2011

Detail Information

Publications10

  1. ncbi request reprint Lipid-lowering Therapies, Glucose Control and Incident Diabetes: Evidence, Mechanisms and Clinical Implications
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, 7 Michal St, Haifa, Israel
    Cardiovasc Drugs Ther 28:361-77. 2014
    ..Suggested mechanisms of how lipid-modifying agents affect glucose control and their clinical implications in this context, are summarized. ..
  2. ncbi request reprint Exercise training and rehabilitation in pulmonary arterial hypertension: rationale and current data evaluation
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Cardiopulm Rehabil Prev 33:263-73. 2013
    ....
  3. doi request reprint The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox"
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center, and Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Respir Med 107:139-46. 2013
    ..There is however, only scarce data regarding the clinical implication of obesity and pulmonary hypertension (PH). Therefore, in the current study, we evaluated the possible prognostic implications of obesity in PH patients...
  4. doi request reprint Risk score model for predicting mortality in advanced heart failure patients followed in a heart failure clinic
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Congest Heart Fail 18:254-61. 2012
    ..69). Simple noninvasive characteristics examined during the initial admission to the HF clinic can serve as prognostic markers for mortality and may help in the process of therapeutic decision-making in patients with HF...
  5. ncbi request reprint Joint impact of body mass index and physical capacity on mortality in patients with systolic heart failure
    Barak Zafrir
    Heart Failure Unit, Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and Heart Failure Clinic, Lin Medical Center, Haifa, Israel Electronic address
    Am J Cardiol 113:1217-21. 2014
    ..Therefore, the combined parameter of BMI × SMWD product is more reliable in predicting long-term mortality risk in patients with systolic HF...
  6. doi request reprint Absence of the α(2c)-adrenoceptor Del322-325 allele is associated with increased mortality in patients with chronic systolic heart failure
    Offer Amir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    J Card Fail 18:925-9. 2012
    ..We investigated the possible clinical association between the presence or absence of the deletion allele and mortality...
  7. ncbi request reprint Single measurement of serum N-terminal pro-brain natriuretic peptide: the best predictor of long-term mortality in patients with chronic systolic heart failure
    Roni Berin
    The Bruce and Ruth Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Intern Med 25:458-62. 2014
    ..Here we evaluated, at the first clinic visit of chronic systolic HF patients, the usefulness of a single serum NP assessment for long-term mortality prediction...
  8. doi request reprint A novel approach to monitoring pulmonary congestion in heart failure: initial animal and clinical experiences using remote dielectric sensing technology
    Offer Amir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Congest Heart Fail 19:149-55. 2013
    ..86; 95% confidence interval, 0.68-0.94; R(2) =0.74). These findings suggest that ReDS technology accurately quantifies lung fluid concentration and has potential for monitoring HF patients through hospitalization and possibly at home...
  9. ncbi request reprint Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives
    Barak Zafrir
    Department of Cardiovascular Medicine, Carmel Medical Center and Heart Failure Center, Lin Medical Center, affiliated with Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Isr Med Assoc J 14:184-9. 2012
    ..We also discuss the various positive inotrope regimens (phosphodiesterase inhibitors, levosimendan, dobutamine) and their interactions with beta blockers in decompensated HF...
  10. doi request reprint Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function
    Barak Zafrir
    Department of Cardiovascular Medicine, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Eur J Intern Med 22:53-6. 2011
    ..There are conflicting reports regarding the characteristics and mortality rates of heart failure patients with preserved (HFPSF) vs. reduced systolic left ventricular function (SHF)...